Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani

References

• ChappuisFSundarSHailuAVisceral leishmaniasis: what are the needs for diagnosis, treatment and control?Nat Rev Microbiol2007587388217938629
   PubMed Web of Science ®Google Scholar
• DawitGGirmaZSimenewKA review on biology. Epidemiology and public health significance of leishmaniasisJ Bacteriol Parasitol201342
   Google Scholar
• TiumanTSSantosAOUeda-NakamuraTRecent advances in leishmaniasis treatmentInt J Infect Dis201115e525e53221605997
   PubMed Web of Science ®Google Scholar
• DubeASinghNSundarSSinghNRefractoriness to the treatment of sodium stibogluconate in Indian kalaazar field isolates persists in in-vitro and in-vivo experimental modelsParasitol Res20059621622315868188
   PubMed Web of Science ®Google Scholar
• RitmeijerKDejenieAAssefaYA comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infectionClin Infect Dis20064335736416804852
   PubMed Web of Science ®Google Scholar
• SundarSJhaTKThakurCPSinhaPKBhattacharyaSKInjectable paromomycin for visceral leishmaniasis in IndiaN Engl J Med20073562571258117582067
   PubMed Web of Science ®Google Scholar
• AthanasiouLVBatziasGCSaridomichelakisMNPharmacokinetics and tolerability of aminosidine after repeated administrations using an optimal dose regimen in healthy dogs and in dogs with leishmaniasisVet Parasitol201420536537024998095
   PubMed Web of Science ®Google Scholar
• WalkerRGThomsonGMaloneKHigh throughput screens yield small molecule inhibitors of Leishmania CRK3: CYC6 cyclin-dependent kinasePLoS Negl Trop Dis20115e103321483720
   PubMed Web of Science ®Google Scholar
• PurkaitBKumarANandiNMechanism of amphotericin B resistance in clinical isolates of Leishmania donovaniAntimicrob Agents Chemother2012561031104122123699
   PubMed Web of Science ®Google Scholar
• DrewsJDrug discovery: a historical perspectiveScience20002871960196410720314
   PubMed Web of Science ®Google Scholar
• SupuranCTScozzafavaACarbonic anhydrase inhibitors and their therapeutic potentialExpert Opin Ther Pat200010575600
   Web of Science ®Google Scholar
• SupuranCTScozzafavaACasiniACarbonic anhydrase inhibitorsMed Res Rev20032314618912500287
   PubMed Web of Science ®Google Scholar
• OgdenRCFlexnerCWProtease Inhibitors in AIDS TherapyNew YorkMarcel Dekker2001
   Google Scholar
• SupuranCTScozzafavaAMastrolorenzoABacterial proteases: current therapeutic use and future prospects for the development of new antibioticsExpert Opin Ther Pat200111221259
   Web of Science ®Google Scholar
• BridgerJamesGaryassigneeChemokine receptor binding heterocyclic compoundsUnited States US Patent7022717 B2200644
   Google Scholar
• BashirROvaisSYaseenSSynthesis of some new 1, 3, 5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agentsBioorg Med Chem Lett2011214301430521664130
   PubMed Web of Science ®Google Scholar
• SenekjiHThe effect of sulfanilamide and trypaflavin on cultures of Leishmania tropicaJ Infect Dis194066111112
   Google Scholar
• SabinABWarrenJTherapeutic effectiveness of certain sulfonamides on infection by an intracellular protozoon (Toxoplasma)Exp Biol Med1942511923
   Google Scholar
• RodanicheECKirsnerJBThe effect of sulfonamide compounds on the growth of Entamoeba histolytica in cultureJ Parasitol194228441449
   Google Scholar
• AndrewsKTFisherGMSumanadasaSDAntimalarial activity of compounds comprising a primary benzene sulfonamide fragmentBioorg Med Chem Lett2013236114611724084158
   PubMed Web of Science ®Google Scholar
• SandersonLYardleyVCroftSLActivity of anti-cancer protein kinase inhibitors against Leishmania sppJ Antimicrob Chemother2014691888189124668412
   PubMed Web of Science ®Google Scholar
• FournelMTrachy-BourgetMCYanPTSulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumorsCancer Res2002624325433012154036
   PubMed Web of Science ®Google Scholar
• PurkaitBSinghRWasnikKUp-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovaniJ Antimicrob Chemother2015701343135625667407
   PubMed Web of Science ®Google Scholar
• SmithDAJonesRMThe sulfonamide group as a structural alert: a distorted story?Curr Opin Drug Discov Devel2008117279
   PubMed Web of Science ®Google Scholar
• YardleyVCroftSLA comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasisInt J Antimicrob Agents20001324324810755238
   PubMed Web of Science ®Google Scholar
• DasSRaniMPandeyKCombination of paromomycin and miltefosine promotes TLR4-dependent induction of antileishmanial immune response in vitroJ Antimicrob Chemother2012672373237822761329
   PubMed Web of Science ®Google Scholar
• SharmaAMadhubalaRUbiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and-resistant strains of Leishmania donovaniJ Immunol20091837719773119933862
   PubMed Web of Science ®Google Scholar
• KarSUkilADasPKSignaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-κB and JAK/STAT pathwaysEur J Immunol20093974175119197936
   PubMed Web of Science ®Google Scholar
• HenryRJThe mode of action of sulfonamidesBacteriol Rev1943717516350088
   PubMedGoogle Scholar
• MadiganMTBrock Biology of Microorganisms11th edSciELOBarcelona; 2005
   Google Scholar
• PetersWRichardsWHAntimalarial Drugs 1: Biological Background, Experimental Methods, and Drug Resistance 2: Current Antimalarials and New Drug Developments (Handbook of Experimental Pharmacology Volume 68 Nos 1 & 2)Springer-VerlagBerlin Heidelberg1984
   Google Scholar
• GrossmanPLRemingtonJSThe effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivoAm J Trop Med Hyg197928445455453442
   PubMed Web of Science ®Google Scholar
• McDougaldLRChemotherapy of coccidiosisLongPLThe Biology of the CoccidiaBaltimore, MDUniversity Park Press1982373427
   Google Scholar
• HardyLMatthewsWNareBBeverleySMBiochemical and genetic tests for inhibitors of Leishmania pteridine pathwaysExp Parasitol1997871581709398595
   PubMed Web of Science ®Google Scholar
• SyrjanenLVermelhoABde Almeida RodriguesICloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasisJ Med Chem2013567372738123977960
   PubMed Web of Science ®Google Scholar
• BasuRBhaumikSBasuJMNaskarKDeTRoySKinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and-resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1-and Th2-like responses in visceral leishmaniasisJ Immunol20051747160717115905560
   PubMed Web of Science ®Google Scholar
• DasLDattaNBandyopadhyaySDasPKSuccessful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell responseJ Immunol20011664020402811238649
   PubMed Web of Science ®Google Scholar
• RoachTKiderlenAFBlackwellJMRole of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strainsInfect Immun199159393539441937752
   PubMed Web of Science ®Google Scholar
• GanttKRGoldmanTLMcCormickMLOxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasiJ Immunol200116789390111441096
   PubMed Web of Science ®Google Scholar
• AwasthiAMathurRKSahaBImmune response to Leishmania infectionIndian J Med Res200411923825815243162
   PubMed Web of Science ®Google Scholar
• RogersKADeKreyGKMbowMLGillespieRDBrodskynCITitusRGType 1 and type 2 responses to Leishmania majorFEMS Microbiol Lett20022091712007646
   PubMed Web of Science ®Google Scholar
• SouzaASGiudiceAPereiraJMResistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-α productionBMC Infect Dis20101020920633260
   PubMed Web of Science ®Google Scholar
• AndersonCFLiraRKamhawiSBelkaidYWynnTASacksDIL-10 and TGF-β control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 miceJ Immunol20081804090409718322219
   PubMed Web of Science ®Google Scholar